Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401005
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-04-30
Brief Title:
SBRT Chemotherapy and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer TNBC
Sponsor:
Hubei Cancer Hospital
Organization:
Hubei Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-30
First Submit QC Date:
May 2 2024
Study First Post Date:
2024-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-21
Last Update Post Date:
2024-06-24
Last Update Post Date Type:
ACTUAL